{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:01:09Z","timestamp":1780624869844,"version":"3.54.1"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"896","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Progressive supranuclear palsy (PSP) or Steele-Richardson-Olszewski syndrome is a neurodegenerative disease of middle and late age. It is under-diagnosed not only by general physicians but also by neurologists. The cause of PSP is not known. Exposure to toxins and viruses has been proposed in the aetiology of PSP without any concrete evidence. The features of PSP resemble those of Parkinson's disease and the two diseases are often confused. Corticobasal degeneration and multisystem atrophy are other differential diagnoses. Despite certain common features with Parkinson's disease, corticobasal degeneration, and mutisystem atrophy, there are important differences that help to differentiate it from these disorders.<\/jats:p>","DOI":"10.1136\/pmj.76.896.333","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:38:40Z","timestamp":1027766320000},"page":"333-336","source":"Crossref","is-referenced-by-count":24,"title":["Progressive supranuclear palsy"],"prefix":"10.1093","volume":"76","author":[{"given":"H U","family":"Rehman","sequence":"first","affiliation":[{"name":"Hull Royal Infirmary , Anlaby Road, Hull HU3 2JZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,6,1]]},"reference":[{"key":"2023042614114957500_B1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy.","volume":"10","author":"Steele","year":"1964","journal-title":"Arch Neurol"},{"key":"2023042614114957500_B2","first-page":"958","article-title":"Sur un syndrome de rigidit\u00e9 \u00e0 predominance axiale, avec perturbation des automatismes oculo-palb\u00e9braux d'origine enc\u00e9phalitique.","volume":"59","author":"Chavany","year":"1951","journal-title":"La Presse Medicale"},{"key":"2023042614114957500_B3","first-page":"831","article-title":"Un cas de maladie de Parkinson avec syndrome pseudobulbaire et pseudo-ophthalmopl\u00e9gique: quelques consid\u00e9rations sur la pathogenie de cette maladie.","volume":"17","author":"Janischewsky","year":"1909","journal-title":"Rev Neurol (Paris)"},{"key":"2023042614114957500_B4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1212\/WNL.38.7.1031","article-title":"Prevalence and natural history of progressive supranuclear palsy.","volume":"38","author":"Golbe","year":"1988","journal-title":"Neurology"},{"key":"2023042614114957500_B5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/jnnp.60.6.615","article-title":"Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.","volume":"60","author":"Litvan","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042614114957500_B6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042614114957500_B7","first-page":"A540","article-title":"The population prevalence of atypical parkinsonian disorders.","volume":"52 (suppl 2)","author":"Schrag","year":"1999","journal-title":"Neurology"},{"key":"2023042614114957500_B8","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.49.5.1284","article-title":"Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County Minnesota, 1976 to 1990.","volume":"49","author":"Bower","year":"1997","journal-title":"Neurology"},{"key":"2023042614114957500_B9","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1212\/WNL.50.6.1637","article-title":"Progressive supranuclear palsy: a survey of disease course.","volume":"50","author":"Santacruz","year":"1998","journal-title":"Neurology"},{"key":"2023042614114957500_B10","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.42.5.1009","article-title":"Progressive supranuclear palsy-like syndrome in two siblings of a consanguineous marriage.","volume":"42","author":"Ohara","year":"1992","journal-title":"Neurology"},{"key":"2023042614114957500_B11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/jnnp.56.5.473","article-title":"Familial progressive supranuclear palsy.","volume":"56","author":"Brown","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042614114957500_B12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1212\/WNL.50.1.270","article-title":"Progressive supranuclear palsy is a recessive disorder in linkage disequilibrium with the tau and not the alpha-synuclein gene.","volume":"50","author":"Higgins","year":"1998","journal-title":"Neurology"},{"key":"2023042614114957500_B13","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.38.10.1546","article-title":"Risk factors for progressive supranuclear palsy.","volume":"38","author":"Davis","year":"1988","journal-title":"Neurology"},{"key":"2023042614114957500_B14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1212\/WNL.47.1.148","article-title":"Follow-up study of risk factors in progressive supranuclear palsy.","volume":"47","author":"Golbe","year":"1996","journal-title":"Neurology"},{"key":"2023042614114957500_B15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ana.410410222","article-title":"Genetic evidence for the involvement of tau in progressive supranuclear palsy.","volume":"41","author":"Conrad","year":"1997","journal-title":"Ann Neurol"},{"key":"2023042614114957500_B16","first-page":"205","article-title":"Progressive supranuclear palsy 1979: an overview.","volume":"4","author":"Brusa","year":"1980","journal-title":"Ital J Neurol Sci"},{"key":"2023042614114957500_B17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ana.410350408","article-title":"Eye movements in parkinsonian syndromes.","volume":"35","author":"Vidailhet","year":"1994","journal-title":"Ann Neurol"},{"key":"2023042614114957500_B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Report of the NINDS-SPSP international workshop.","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"2023042614114957500_B19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/brain\/118.3.759","article-title":"The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal.","volume":"118","author":"Daniel","year":"1995","journal-title":"Brain"},{"key":"2023042614114957500_B20","first-page":"407","article-title":"Steele-Richardson-Olszewski disease without ophthalmoplegia. Six clinico-anatomic cases.","volume":"139","author":"Dubas","year":"1983","journal-title":"Rev Neurol (Paris)"},{"key":"2023042614114957500_B21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/mds.870070410","article-title":"Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report.","volume":"7","author":"De Bruin","year":"1992","journal-title":"Mov Disord"},{"key":"2023042614114957500_B22","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/jnnp.54.12.1121-a","article-title":"Progressive supranuclear palsy as the sole manifestation of systemic Whipple's disease treated with pefloxacine (letter).","volume":"54","author":"Amarenco","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042614114957500_B23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/mds.870090402","article-title":"Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes: a review of 90 pathologically verified cases.","volume":"9","author":"De Bruin","year":"1994","journal-title":"Mov Disord"},{"key":"2023042614114957500_B24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archneur.1995.00540270090024","article-title":"Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease.","volume":"52","author":"Colosimo","year":"1995","journal-title":"Arch Neurol"},{"key":"2023042614114957500_B25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.410020509","article-title":"The ocular motor defects in progressive supranuclear palsy.","volume":"2","author":"Troost","year":"1977","journal-title":"Ann Neurol"},{"key":"2023042614114957500_B26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/jnnp.64.2.190","article-title":"Truncal muscle tonus in progressive supranuclear palsy.","volume":"64","author":"Tanigawa","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023042614114957500_B27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1212\/WNL.43.3_Part_1.563","article-title":"Perceptual analysis of speech disorders in progressive supranuclear palsy.","volume":"43","author":"Kluin","year":"1993","journal-title":"Neurology"},{"key":"2023042614114957500_B28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archneur.1990.00530050077015","article-title":"Frontal lobe function in progressive supranuclear palsy.","volume":"47","author":"Grafman","year":"1990","journal-title":"Arch Neurol"},{"key":"2023042614114957500_B29","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1212\/WNL.45.8.1477","article-title":"The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease.","volume":"45","author":"Pillon","year":"1995","journal-title":"Neurology"},{"key":"2023042614114957500_B30","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/WNL.47.5.1184","article-title":"Neuropsychiatric aspects of progressive supranuclear palsy.","volume":"47","author":"Litvan","year":"1997","journal-title":"Neurology"},{"key":"2023042614114957500_B31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/brain\/120.1.75","article-title":"Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.","volume":"120","author":"Leiguarda","year":"1997","journal-title":"Brain"},{"key":"2023042614114957500_B32","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1212\/WNL.41.5.634","article-title":"Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.","volume":"41","author":"Pillon","year":"1991","journal-title":"Neurology"},{"key":"2023042614114957500_B33","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","article-title":"Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).","volume":"44","author":"Hauw","year":"1994","journal-title":"Neurology"},{"key":"2023042614114957500_B34","first-page":"191","article-title":"Progressive supranuclear palsy: anatomoclinical and biochemical considerations.","volume":"45","author":"Agid","year":"1987","journal-title":"Adv Neurol"},{"key":"2023042614114957500_B35","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.40.11.1739","article-title":"Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration.","volume":"40","author":"Malessa","year":"1990","journal-title":"Neurology"},{"key":"2023042614114957500_B36","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1212\/WNL.41.10.1593","article-title":"Progressive supranuclear palsy: loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formation.","volume":"41","author":"Malessa","year":"1991","journal-title":"Neurology"},{"key":"2023042614114957500_B37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ana.410180503","article-title":"Dopaminergic and cholinergic lesions in progressive supranuclear palsy.","volume":"18","author":"Ruberg","year":"1985","journal-title":"Ann Neurology"},{"key":"2023042614114957500_B38","first-page":"344","article-title":"Horizontal, vertical, and oblique saccades in progressive supranuclear palsy.","volume":"29","author":"FitzGibbon","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2023042614114957500_B39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archneur.1993.00540050063017","article-title":"Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography.","volume":"50","author":"","year":"1993","journal-title":"Arch Neurol"},{"key":"2023042614114957500_B40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ana.410180504","article-title":"Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.","volume":"18","author":"Kish","year":"1985","journal-title":"Ann Neurol"},{"key":"2023042614114957500_B41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.45.1.127","article-title":"Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA.","volume":"45","author":"Levy","year":"1995","journal-title":"Neurology"},{"key":"2023042614114957500_B42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mds.870030310","article-title":"Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy.","volume":"3","author":"Maloteaux","year":"1988","journal-title":"Mov Disord"},{"key":"2023042614114957500_B43","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/brain\/118.4.951","article-title":"Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome. A (11C) diprenorphine PET study.","volume":"118","author":"Burn","year":"1995","journal-title":"Brain"},{"key":"2023042614114957500_B44","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1212\/WNL.38.6.943","article-title":"Brain amino acids and glutathione in progressive supranuclear palsy.","volume":"38","author":"Perry","year":"1988","journal-title":"Neurology"},{"key":"2023042614114957500_B45","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/brain\/115.4.1181","article-title":"The auditory startle response in the Steele-Richardson-Olszewski syndrome and Parkinson's disease.","volume":"115","author":"Vidailhet","year":"1992","journal-title":"Brain"},{"key":"2023042614114957500_B46","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/brain\/120.10.1877","article-title":"Distinctive abnormalities of facial reflexes in patients with progressive supranuclear palsy.","volume":"120","author":"Valls-Sole","year":"1997","journal-title":"Brain"},{"key":"2023042614114957500_B47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00127893-199801000-00003","article-title":"Progressive supranuclear palsy: staring into the past, moving into the future.","volume":"4","author":"Litvan","year":"1998","journal-title":"The Neurologist"},{"key":"2023042614114957500_B48","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ana.410410509","article-title":"Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy.","volume":"41","author":"Yamauchi","year":"1997","journal-title":"Ann Neurol"},{"key":"2023042614114957500_B49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-3-7091-6641-3_21","article-title":"Cholinergic approaches to the treatment of progressive supranuclear palsy.","volume":"42","author":"Litvan","year":"1994","journal-title":"J Neural Transm Suppl"},{"key":"2023042614114957500_B50","first-page":"1013","article-title":"A case of progressive supranuclear palsy showing improvement of rigidity, nuchal dystonia and autonomic failure with trazodone.","volume":"34","author":"Kato","year":"1994","journal-title":"Rinsho Shinkeigaku-Clin Neurol"},{"key":"2023042614114957500_B51","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-3-7091-6641-3_22","article-title":"Therapy for progressive supranuclear palsy: past and future.","volume":"42","author":"Cole","year":"1994","journal-title":"J Neural Transm Suppl"},{"key":"2023042614114957500_B52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF02337027","article-title":"Treatment of progressive supranuclear palsy with methysergide. A clinical study.","volume":"12","author":"Di Trapani","year":"1991","journal-title":"Ital J Neurol Sci"},{"key":"2023042614114957500_B53","first-page":"606","article-title":"A case of progressive supranuclear palsy dramatically improved with L-threo-3,4-dihydroxyphenylserine.","volume":"32","author":"Maruyama","year":"1992","journal-title":"Rinsho Shinkeigaku-Clin Neurol"},{"key":"2023042614114957500_B54","first-page":"317","article-title":"A case of progressive supranuclear palsy showing marked improvements of frontal hypoperfusion, as well as parkinsonism with amitriptyline.","volume":"33","author":"Asanuma","year":"1993","journal-title":"Rinsho Shinkeigaku-Clin Neurol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/76\/896\/333\/50044140\/postgradmedj-76-333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/76\/896\/333\/50044140\/postgradmedj-76-333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T14:45:52Z","timestamp":1682520352000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/76\/896\/333\/7039984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6,1]]},"references-count":54,"journal-issue":{"issue":"896","published-online":{"date-parts":[[2000,6,1]]},"published-print":{"date-parts":[[2000,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pmj.76.896.333","relation":{},"ISSN":["1469-0756","0032-5473"],"issn-type":[{"value":"1469-0756","type":"electronic"},{"value":"0032-5473","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,6]]},"published":{"date-parts":[[2000,6,1]]}}}